Interleukin-2 therapy does not exacerbate multiple sclerosis

Neurology. 1997 Aug;49(2):633-4. doi: 10.1212/wnl.49.2.633.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Carcinoma, Renal Cell / drug therapy
  • Carcinoma, Renal Cell / secondary
  • Female
  • Humans
  • Interleukin-2 / therapeutic use*
  • Kidney Neoplasms / drug therapy
  • Kidney Neoplasms / secondary
  • Middle Aged
  • Multiple Sclerosis / physiopathology*

Substances

  • Interleukin-2